Used in research to study CCR8 receptor function, particularly in immune cell signaling and migration. Employed for screening potential anti-inflammatory and anti-cancer drugs, especially in T cell-mediated diseases and tumor microenvironment studies. Supports development of monoclonal antibodies and small molecule inhibitors targeting CCR8 for therapeutic use in autoimmune disorders and oncology. Provides consistent and scalable expression of the receptor for high-throughput assays and binding studies.